Pelthos Therapeutics Inc. reports material agreement in SEC 8-K

Pelthos Therapeutics Inc. filed an 8-K covering a material definitive agreement, a direct financial obligation, an unregistered sale of equity securities, and SEC Item 3.03. Nelo verified the filing topics against the primary SEC document. This is a company disclosure filed with the SEC, not an SEC enforcement action.